BeStock  
Stocks › TRAX

First Tracks Biotherapeutics TRAX

US equityMarket cap rank #3180
$30.59 −$0.80 (-2.55%)
Pre-market · Oct 8, 7:00 am ET · After hours $29.99 -1.96%
Open$30.91
Prev close$31.39
Day range$30.53 – $31.75
Volume355.5K
Market cap$1.09B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$34.94M+23.9% YoY
Net profit-$33.37M+21.4% YoY
Diluted EPS-$0.95+22.2% YoY
Free cash flow-$31.94M+17.4% YoY
Operating cash flow-$31.92M

Revenue, last 4 quarters

$0.0Mar '25$0.0Jun '25$0.0Mar '26$0.0Jun '26

Net profit, last 4 quarters

$-47.2MMar '25$-42.4MJun '25$-50.5MMar '26$-33.4MJun '26

Diluted EPS by quarter

-1.36Mar '25-1.22Jun '25-1.45Mar '26-0.95Jun '26

Free cash flow by quarter

$-45.0MMar '25$-38.7MJun '25$-32.6MMar '26$-31.9MJun '26

Profitability & balance sheet

Current ratio14.28
Liabilities / assets7.8%
Cash & investments$168.02M
Total debt$1.90M
Net cash (debt)$166.12M

Income statement

Line item 2026 Q2 2026 Q1 2025 Q2 2025 Q1 2024 ANNUAL
Net Profit -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Net Income to Parent Company -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Net Income to Common Stockholders -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Basic EPS -$0.95 -$1.45 -$1.22 -$1.36 -$4.71
Diluted EPS -$0.95 -$1.45 -$1.22 -$1.36 -$4.71
Profit from Continuing Operations -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Selling and Admin Expenses $9.29M $18.86M $6.63M $9.82M $28.76M
-General & Admin Expense $9.29M $18.86M $6.63M $9.82M $28.76M
Research & Development $25.64M $33.96M $39.27M $41.47M $152.35M
Operating Profit -$34.94M -$52.81M -$45.90M -$51.28M -$181.10M
Net Non-Operating Interest Income (Expense) $1.56M $2.33M $3.47M $4.09M $17.38M
Non-Operating Interest Income $1.56M $2.33M $3.47M $4.09M $17.38M
Other Income (Expense) -$1,000.00 -$1,000.00 -$13,000.00 -$7,000.00 $14,000.00
Other Non-Operating Income (Expenses) -$1,000.00 -$1,000.00 -$13,000.00 -$7,000.00 $14,000.00
Pretax Profit -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Operating Expense $34.94M $52.81M $45.90M $51.28M $181.10M

Balance sheet

Line item 2026 Q2 2026 Q1 2024 ANNUAL 2023 ANNUAL
Gains/Losses Not Affecting Retained Earnings $0.00 -$146,000.00 $305,000.00 -$797,000.00
Retained Earnings -$24.58M – – –
Additional Paid-In Capital $193.34M – – –
-Preferred Stock $0.00 – – –
-Common Stock $35,000.00 – – –
Total Current Liabilities $12.45M $33.11M $36.18M $18.22M
Capital Stock $35,000.00 – – –
Stockholders' Equity $168.80M $257.46M $391.60M $409.85M
-Cash and Cash Equivalents $168.02M $248.47M $123.08M $35.97M
-Short Term Investments $0.00 $37.99M $262.29M $354.94M
Receivables $5.07M – – –
-Other Receivables $5.07M – – –
Prepaid Assets $2.47M – – –
Other Current Assets $2.18M $2.95M $4.56M $7.65M
Total Non-Current Assets $5.40M $1.17M $51.96M $45.55M
Net PPE $5.40M $1.17M $16.23M $18.27M
-Gross PPE $12.67M $8.35M $22.83M $24.49M
-Accumulated Depreciation -$7.28M -$7.17M -$6.60M -$6.22M
Cash and Cash Equivalents & Short-Term Investments $168.02M $286.46M $385.37M $390.90M
Total Current Assets $177.75M $289.40M $389.93M $398.56M
Total Equity $168.80M $257.46M $391.60M $409.85M
-Long Term Capital Lease Obligation $1.90M $0.00 $14.11M $16.04M
Long Term Debt and Capital Lease Obligation $1.90M $0.00 $14.11M $16.04M
Total Non-Current Liabilities $1.90M $0.00 $14.11M $16.04M
-Current Capital Lease Obligation $2.44M $0.00 $1.93M $1.78M
Short-Term Debt and Capital Lease Obligation $2.44M – $1.93M $1.78M
Current Accrued Expenses $5.49M $20.76M $23.05M $9.43M
-Accounts Payable $2.55M $7.50M $3.79M $2.43M
Payables $2.55M $7.50M $3.79M $2.43M
Total Assets $183.14M $290.58M $441.89M $444.11M
Total Liabilities $14.34M $33.11M $50.30M $34.26M
Other Equity Interests – $257.61M $391.29M $410.65M
Investments and Advances – – $35.47M $27.03M
Other Non-Current Assets – – $256,000.00 $256,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q2 2025 Q1 2024 ANNUAL
Operating Cash Flow -$31.92M -$32.56M -$38.64M -$45.01M -$125.81M
Ending Cash Balance $168.02M $248.47M $44.30M $98.64M $123.08M
Net Other Financing Charges -$235.07M $7.85M -$52.11M $5.72M $117.52M
Net Cash Flow from Continuing Financing Activities -$48.51M $7.85M -$52.11M $5.72M $117.52M
Financing Cash Flow -$48.51M $7.85M -$52.11M $5.72M $117.52M
Net Investment Purchase and Sale $0.00 $35.00M $36.44M $14.88M $95.76M
Change in Working Capital -$7.22M $6.30M -$2.85M -$4.50M $18.99M
Net PPE Purchase and Sale -$25,000.00 -$17,000.00 -$39,000.00 -$35,000.00 -$358,000.00
Net Cash Flow from Continuing Investing Activities -$25,000.00 $34.98M $36.40M $14.85M $95.40M
Net cash flow from investing -$25,000.00 $34.98M $36.40M $14.85M $95.40M
-Change in Other Current Liabilities -$93,000.00 $0.00 -$479,000.00 -$462,000.00 -$1.78M
-Change in Payables and Accrued Expense $5.24M $4.15M -$3.46M -$3.59M $17.81M
-Change in Prepaid Assets -$12.36M $2.16M $1.08M -$443,000.00 $2.95M
Net Income from Continuing Operations -$33.37M -$50.48M -$42.45M -$47.20M -$163.71M
Net cash flow from continuing operations -$31.92M -$32.56M -$38.64M -$45.01M -$125.81M
Depreciation & Depletion & Amortization $207,000.00 $125,000.00 $601,000.00 $606,000.00 $2.40M
Free Cash Flow -$31.94M -$32.58M -$38.68M -$45.04M -$126.16M
Net Change in Cash -$80.45M $10.27M -$54.34M -$24.44M $87.12M
Beginning Cash Balance $248.47M $238.20M $98.64M $123.08M $35.97M

Discussion

No comments yet — be the first to weigh in on TRAX.

Leave a comment

Scroll to Top